Hikma Pharmaceuticals USA INC Recalls
5 recalls on record in the United States
Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx onl
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
View recall details →
Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (N
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
View recall details →
Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottle
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
View recall details →
Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
View recall details →
Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Onl
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
View recall details →